PR Newswire Clinical TrialsOriginal article
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
Data ReadoutpositiveMyriadPositive
AI Analysis
Summary
Aroa Biosurgery's interim MASTRR Registry analysis of 411 patients demonstrates low infection rates with Myriad bioscaffold in complex soft tissue reconstruction, representing the largest published prospective bioscaffold analysis in this application.
Clinical Trial Data
Primary Endpoint
Met
Patients
411
Outcome Details
411-patient study reports low infection rates in complex soft tissue reconstruction
Importance:6/10
Sentiment:
0.70
soft tissue reconstructionbioscaffoldregistry analysisprospective studymedical device
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 7, 2026 12:46 AM